Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Camurus AB (CAMRF)
OTHER OTC:CAMRF
Camurus AB (CAMRF) Stock Price & Analysis
8 Followers
CAMRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$21.81 - $56.48
Previous Close$44.72
Volume9.00
Average Volume (3M)204.00
Market Cap
$2.57B
Enterprise Value$2.52B
Total Cash (Recent Filing)kr565.54M
Total Debt (Recent Filing)kr26.22M
Price to Earnings (P/E)60.8
Beta0.71
Next Earnings
May 08, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.73
Shares Outstanding57,623,618
10 Day Avg. Volume1
30 Day Avg. Volume204
Standard Deviation0.33
R-Squared0.22
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Camurus AB News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.38% Mutual Funds
2.56% Other Institutional Investors
96.05% Public Companies and
Individual Investors
CAMRF FAQ
What was Camurus AB’s price range in the past 12 months?
Camurus AB lowest stock price was $21.81 and its highest was $56.48 in the past 12 months.
What is Camurus AB’s market cap?
Currently, no data Available
When is Camurus AB’s upcoming earnings report date?
Camurus AB’s upcoming earnings report date is May 08, 2024 which is today.
How were Camurus AB’s earnings last quarter?
Camurus AB released its earnings results on Feb 15, 2024. The company reported -$0.025 earnings per share for the quarter, beating the consensus estimate of -$0.162 by $0.137.
Is Camurus AB overvalued?
According to Wall Street analysts Camurus AB’s price is currently Overvalued.
Does Camurus AB pay dividends?
Camurus AB does not currently pay dividends.
What is Camurus AB’s EPS estimate?
Camurus AB’s EPS estimate is $0.1.
How many shares outstanding does Camurus AB have?
Camurus AB has 57,623,620 shares outstanding.
What happened to Camurus AB’s price movement after its last earnings report?
Camurus AB reported an EPS of -$0.025 in its last earnings report, beating expectations of -$0.162. Following the earnings report the stock price went down -15.55%.
Which hedge fund is a major shareholder of Camurus AB?
Currently, no hedge funds are holding shares in CAMRF
---
Camurus AB Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
105.04%
12-Months-Change
Fundamentals
Return on Equity
33.49%
Trailing 12-Months
Asset Growth
50.89%
Trailing 12-Months
Company Description
Camurus AB
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer and endocrine diseases. The company has Europe, North America and Other geographical areas geographic segments. It derives the majority of its revenues from North America geographic segment. The company's product pipeline includes CAM2038, CAM2029, CAM2032 product candidates.
---
CAMRF Company Deck
---
CAMRF Earnings Call
Q4 2024
0:00 / 0:00
---
CAMRF Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CAMRF
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+105.00%
reiterated a buy rating 4 months ago
Copying Brian Balchin's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +105.00% per trade.
---